# ELIQUIS
> **NDA202155** · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2012-12-28
## Drug
- **FDA Application Number:** NDA202155
- **Application type:** New Drug Application
- **Brand name:** ELIQUIS
- **Generic name:** Apixaban
- **Active ingredients:** APIXABAN
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL MYERS SQUIBB
- **First approval:** 2012-12-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202155)
---
*AI Analytics · CC0 1.0*